CASI Pharmaceuticals (CASI) has announced a strategic move to divest its Chinese operations through a $20 million agreement with Kaixin Pharmaceuticals, a company owned by CASI’s Chairman and CEO, Dr.

Energy Transfer's resilience amid trade war and market uncertainties underscores its solid fundamentals. Check out why I ...

Kirkland's expands credit agreement with Beyond Inc., fueling growth of brand-name stores. Learn how it strengthens finances ...

Federal Signal (FSS) upgraded to Overweight by KeyBanc, citing growth strategies, acquisitions, and strong margins.

The US tariff on China falls to 30% from 145%, while China's tariff on the US falls to 10% from 125%. Click to read.

Hims & Hers delivered impressive Q1 2025 results, with 111% y/y revenue growth and 38% y/y subscriber growth. Check out why I ...

AT&T’s sharp rebound, strong cash flow, and strategic focus on fiber and 5G support its growth and value potential. Check out ...

Plymouth Industrial REIT's focus on the Golden Triangle raises questions on capital strategy with shareholder dilution & ...

Duke Energy is seeing record electricity load growth, prompting major investments in nuclear, gas, and grid upgrade. Read why ...

A. O. Smith leads in water heaters with steady financials but faces growth headwinds after policy changes limit future upside ...

Remitly Global's revenue grew 34.4% y/y, active users up 29% y/y, and adj. EBITDA margin hit 16.2%. Find out why I'm ...

Gabelli Equity Trust has a place in a portfolio, as its holdings are very different from those of most other closed-end funds ...